Recombinant Human DEFa2 Protein，His

DEFa2, a member of the defensin family, plays a vital role in the innate immune response. Defensins are small cationic peptides that exhibit antimicrobial activity against a broad range of pathogens, including bacteria, fungi, and viruses. Research into DEFa2 has gained momentum due to its potential therapeutic applications and its role in host defense mechanisms. Emerging studies have shown that DEFa2 possesses not only direct antimicrobial properties but also regulatory functions in immune modulation, influencing processes such as inflammation and wound healing. Understanding the structural characteristics and functional mechanisms of DEFa2 is crucial for developing novel antimicrobial agents, particularly in the face of rising antibiotic resistance. Moreover, DEFa2's involvement in various physiological and pathological processes highlights its significance in health and disease. As a recombinant protein, DEFa2 can be engineered and produced for detailed biochemical and biophysical studies, paving the way for its application in drug development and therapeutic interventions. Overall, the ongoing research on DEFa2 not only enhances our knowledge of host-pathogen interactions but also opens new avenues for innovative treatments targeting infectious diseases.